 Connection
Richard Tobin to Female
This is a "connection" page, showing publications Richard Tobin has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.070 |
|
|
|
-
Tobin RP, Jordan KR, Robinson WA, Davis D, Borges VF, Gonzalez R, Lewis KD, McCarter MD. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. Int Immunopharmacol. 2018 Oct; 63:282-291.
Score: 0.020
-
A Turner J, D'Antonio M, Montane HN, MacBeth M, Katsnelson E, Robinson WA, Tobin RP, Couts KL, Markovic SN, Torres RM. Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches. Front Immunol. 2026; 17:1829486.
Score: 0.008
-
Iveson MH, Mukherjee M, Davidson EM, Zhang H, Sherlock L, Ball EL, Mair G, Hosking A, Whalley H, Poon MTC, Wardlaw JM, Kent DM, Tobin R, Grover C, Alex B, Whiteley W. Clinically reported covert cerebrovascular disease and risk of neurological disease: a whole-population cohort of 367 988 people using natural language processing. J Neurol Neurosurg Psychiatry. 2026 Jun 12; 97(7):630-638.
Score: 0.008
-
Turner JA, Van Gulick RJ, Robinson WA, Mughal T, Tobin RP, MacBeth ML, Holman B, Classon A, Bagby SM, Yacob BW, Hartman SJ, Silverman I, Vorwald VM, Gorden N, Gonzalez R, Gay LM, Ali SM, Benson A, Miller VA, Ross JS, Pitts TM, Rioth MJ, Lewis KD, Medina T, McCarter MD, Gonzalez R, Couts KL. Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling. Int J Cancer. 2024 11 15; 155(10):1792-1807.
Score: 0.007
-
Borgers JSW, Tobin RP, Vorwald VM, Smith JM, Davis DM, Kimball AK, Clambey ET, Couts KL, McWilliams JA, Jordan KR, Torphy RJ, Schulick R, McCarter MD. High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes. Immunohorizons. 2020 02 18; 4(2):82-92.
Score: 0.005
-
Turner JA, Bemis JGT, Bagby SM, Capasso A, Yacob BW, Chimed TS, Van Gulick R, Lee H, Tobin R, Tentler JJ, Pitts T, McCarter M, Robinson WA, Couts KL. BRAF fusions identified in melanomas have variable treatment responses and phenotypes. Oncogene. 2019 02; 38(8):1296-1308.
Score: 0.005
-
Chatterjee P, Chiasson VL, Seerangan G, De Guzman E, Milad M, Bounds KR, Gasheva O, Tobin RP, Hatahet M, Kopriva S, Jones KA, Newell-Rogers MK, Mitchell BM. Depletion of MHC class II invariant chain peptide or ?-d T-cells ameliorates experimental preeclampsia. Clin Sci (Lond). 2017 08 01; 131(15):2047-2058.
Score: 0.005
-
Jordan KR, Kapoor P, Spongberg E, Tobin RP, Gao D, Borges VF, McCarter MD. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Cancer Immunol Immunother. 2017 Apr; 66(4):503-513.
Score: 0.004
-
Chatterjee P, Chiasson VL, Seerangan G, Tobin RP, Kopriva SE, Newell-Rogers MK, Mitchell BM. Cotreatment with interleukin 4 and interleukin 10 modulates immune cells and prevents hypertension in pregnant mice. Am J Hypertens. 2015 Jan; 28(1):135-42.
Score: 0.004
-
Chatterjee P, Kopriva SE, Chiasson VL, Young KJ, Tobin RP, Newell-Rogers K, Mitchell BM. Interleukin-4 deficiency induces mild preeclampsia in mice. J Hypertens. 2013 Jul; 31(7):1414-23; discussion 1423.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|